4 reasons to invest
in NanoEcho
In a short time, NanoEcho has transitioned from being a research-focused company to today being a medical technology product development company, with both clinical and commercial focus.
01
Rapidly growing demand for reliable rectal cancer diagnostics
02
NanoEcho has developed an innovative method with significant market potential
03
Potential to generate substantial health economic benefits
04
A dynamic company with high intellectual capital
NanoEcho’s innovative method, with its high precision, aims to facilitate the differentiation between diseased and healthy tissue and at the same time determine a more precise localization of cancerous tissue. The goal is to provide a more reliable diagnosis of, for example cancer diseases, that has the potential to contribute to cost-effectiveness in the health care.
We use cookies to enhance your experience on our website and analyze our traffic. By clicking ‘Accept,’ you consent to our use of cookies. You can learn more about the types of cookies we use and how to manage them in our privacy policy.